Artículo original
Mortalidad por cáncer de próstata en la rama española del European Randomized Study of Screening for Prostate Cancer (ERSPC). Resultados tras 15 años de seguimiento
Mortality Due to Prostate Cancer in the Spanish Arm of the European Randomized Study of Screening for Prostate Cancer (ERSPC). Results After a 15-Year Follow-Up
a Servicio de Urología, Hospital Universitario Infanta Cristina, Parla, Madrid, España
b Rama española del European Randomized Study of Screening for Prostate Cancer
c Servicio de Urología, Hospital Universitario de Fuenlabrada, Fuenlabrada, Madrid, España
d Servicio de Urología, Hospital Universitario Madrid-Norte Sanchinarro, Madrid, España
e Instituto Nacional de Estadística, Madrid, España
Leído
3086
Vecesse ha leído el artículo
505
Total PDF
2581
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 0 | 1 | 1 |
| 2025 11 | 0 | 3 | 3 |
| 2025 9 | 0 | 1 | 1 |
| 2025 7 | 0 | 3 | 3 |
| 2025 2 | 0 | 2 | 2 |
| 2024 12 | 0 | 1 | 1 |
| 2024 11 | 0 | 1 | 1 |
| 2024 7 | 0 | 1 | 1 |
| 2024 3 | 0 | 2 | 2 |
| 2024 2 | 0 | 2 | 2 |
| 2024 1 | 0 | 1 | 1 |
| 2023 12 | 0 | 1 | 1 |
| 2023 11 | 0 | 1 | 1 |
| 2023 10 | 0 | 1 | 1 |
| 2023 9 | 0 | 4 | 4 |
| 2023 8 | 0 | 1 | 1 |
| 2023 7 | 0 | 2 | 2 |
| 2023 6 | 0 | 2 | 2 |
| 2023 5 | 0 | 4 | 4 |
| 2023 3 | 5 | 2 | 7 |
| 2023 2 | 0 | 2 | 2 |
| 2022 1 | 0 | 2 | 2 |
| 2022 12 | 0 | 6 | 6 |
| 2022 11 | 0 | 4 | 4 |
| 2022 10 | 0 | 5 | 5 |
| 2022 9 | 0 | 2 | 2 |
| 2022 8 | 0 | 5 | 5 |
| 2022 5 | 0 | 2 | 2 |
| 2022 3 | 0 | 3 | 3 |
| 2022 2 | 0 | 5 | 5 |
| 2021 1 | 0 | 1 | 1 |
| 2021 12 | 0 | 5 | 5 |
| 2021 11 | 0 | 2 | 2 |
| 2021 10 | 0 | 5 | 5 |
| 2021 9 | 0 | 1 | 1 |
| 2021 8 | 0 | 1 | 1 |
| 2021 7 | 0 | 1 | 1 |
| 2021 6 | 0 | 1 | 1 |
| 2021 5 | 0 | 2 | 2 |
| 2021 4 | 0 | 2 | 2 |
| 2021 3 | 0 | 8 | 8 |
| 2020 1 | 0 | 3 | 3 |
| 2020 8 | 0 | 2 | 2 |
| 2020 5 | 0 | 1 | 1 |
| 2020 4 | 0 | 2 | 2 |
| 2020 3 | 0 | 3 | 3 |
| 2020 2 | 0 | 1 | 1 |
| 2020 1 | 1 | 6 | 7 |
| 2019 12 | 0 | 2 | 2 |
| 2019 11 | 0 | 3 | 3 |
| 2019 9 | 0 | 4 | 4 |
| 2019 8 | 1 | 4 | 5 |
| 2019 7 | 0 | 6 | 6 |
| 2019 6 | 0 | 8 | 8 |
| 2019 5 | 0 | 8 | 8 |
| 2019 4 | 0 | 9 | 9 |
| 2019 2 | 0 | 2 | 2 |
| 2019 1 | 0 | 1 | 1 |
| 2018 12 | 0 | 7 | 7 |
| 2018 5 | 0 | 1 | 1 |
| 2018 4 | 0 | 1 | 1 |
| 2018 2 | 11 | 0 | 11 |
| 2018 1 | 6 | 0 | 6 |
| 2017 12 | 7 | 0 | 7 |
| 2017 11 | 17 | 4 | 21 |
| 2017 10 | 13 | 5 | 18 |
| 2017 9 | 13 | 5 | 18 |
| 2017 8 | 27 | 3 | 30 |
| 2017 7 | 21 | 4 | 25 |
| 2017 6 | 23 | 4 | 27 |
| 2017 5 | 23 | 6 | 29 |
| 2017 4 | 18 | 4 | 22 |
| 2017 3 | 22 | 33 | 55 |
| 2017 2 | 21 | 2 | 23 |
| 2016 1 | 13 | 2 | 15 |
| 2016 12 | 34 | 8 | 42 |
| 2016 11 | 45 | 5 | 50 |
| 2016 10 | 44 | 18 | 62 |
| 2016 9 | 34 | 6 | 40 |
| 2016 8 | 32 | 3 | 35 |
| 2016 7 | 31 | 3 | 34 |
| 2016 6 | 24 | 7 | 31 |
| 2016 5 | 30 | 14 | 44 |
| 2016 4 | 30 | 7 | 37 |
| 2016 3 | 17 | 10 | 27 |
| 2016 2 | 31 | 9 | 40 |
| 2015 1 | 32 | 16 | 48 |
| 2015 12 | 31 | 9 | 40 |
| 2015 11 | 30 | 4 | 34 |
| 2015 10 | 33 | 6 | 39 |
| 2015 9 | 29 | 9 | 38 |
| 2015 8 | 32 | 3 | 35 |
| 2015 7 | 31 | 7 | 38 |
| 2015 6 | 17 | 4 | 21 |
| 2015 5 | 17 | 6 | 23 |
| 2015 4 | 33 | 18 | 51 |
| 2015 3 | 32 | 3 | 35 |
| 2015 2 | 42 | 4 | 46 |
| 2015 1 | 36 | 14 | 50 |
| 2014 12 | 56 | 9 | 65 |
| 2014 11 | 46 | 7 | 53 |
| 2014 10 | 70 | 7 | 77 |
| 2014 9 | 70 | 10 | 80 |
| 2014 8 | 122 | 8 | 130 |
| 2014 7 | 63 | 10 | 73 |
| 2014 6 | 0 | 3 | 3 |
| 2014 5 | 4 | 1 | 5 |
| 2014 1 | 2 | 1 | 3 |
| 2013 12 | 4 | 2 | 6 |
| 2013 11 | 11 | 4 | 15 |
| 2013 10 | 8 | 2 | 10 |
| 2013 9 | 3 | 1 | 4 |
| 2012 6 | 1133 | 0 | 1133 |
Mostrar todo
